過敏診斷市場規模、佔有率、按產品類型、過敏原、測試類型和地區分類的成長分析 - 產業預測，2024-2031 年

2022 年全球過敏診斷市場規模約為 43 億美元，高於 2023 年的 48 億美元，預測期內（2024-2031 年）複合年成長率為 11%，到 2031 年將達到 111 億美元。達到美元。

由於環境變化、污染和生活方式的改變，全球過敏性疾病盛行率在都市區和農村地區變得越來越普遍，這推動了過敏診斷市場的顯著成長。擴大採用體外診斷 (IVD) 測試、對更準確、更快速的測試解決方案的需求以及患者和醫療保健專業人員的意識不斷增強等因素正在推動市場擴張。此外，政府和衛生組織正在進行旨在提高人們對過敏的認知的宣傳活動，這進一步推動了對診斷工具的需求。此外，高通量診斷系統和實驗室自動化的發展等技術進步顯著提高了診斷準確性和效率。然而，挑戰包括過敏診斷測試的高成本以及新興市場獲得先進醫療保健的機會有限。市場上也見證了主要企業之間的策略性合併、收購和聯盟，重點是豐富其診斷產品組合併擴大其地理覆蓋範圍。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價格分析
• 專利分析
• 價值鏈分析
• 供應鏈分析
• 貿易分析
• 技術分析
• 客戶和購買標準分析

過敏診斷市場：依產品/服務分類

• 市場概況
• 消耗品
• 裝置
  • 免疫檢測分析儀
  • 光度計
  • 其他樂器
• 服務

過敏診斷市場：按測試類型

• 市場概況
• 體內測試
  • 皮膚點刺試驗
  • 斑貼試驗
  • 其他體內測試
• 體外試驗

過敏診斷市場：依過敏原分類

• 市場概況
• 吸入性過敏原
• 食物過敏原
• 藥物過敏原
• 其他過敏原

過敏診斷市場：依最終用戶分類

• 市場概況
• 醫院附設實驗室和診所
• 診斷實驗室
• 學術研究所
• 其他最終用戶

過敏診斷市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Danaher Corporation
• Siemens Healthineers Ag
• Eurofins Scientific
• Biomerieux Sa
• Romer Labs Division Holding Gmbh
• Hollisterstier Allergy
• Omega Diagnostics Group Plc
• Hycor Biomedical
• R-Biopharm Ag
• Astra Biotech Gmbh
• Erba Group
• Dst Diagnostische Systeme & Technologien Gmbh
• Dr. Fooke Laboratorien GmbH

Global Allergy Diagnostics Market size was valued at around 4.3 billion in 2022 and is expected to rise from USD 4.8 billion in 2023 to reach a value of USD 11.1 billion by 2031, at a CAGR of 11% over the forecast period (2024-2031).

The allergy diagnostics market is experiencing substantial growth driven by the rising prevalence of allergic diseases globally, which are becoming increasingly common in both urban and rural areas due to environmental changes, pollution, and lifestyle shifts. Factors like the increasing adoption of in-vitro diagnostic (IVD) tests, the demand for more accurate and quick testing solutions, and rising awareness among patients and healthcare professionals are pushing market expansion. Governments and health organizations are also implementing campaigns aimed at raising awareness about allergies, which is further driving demand for diagnostic tools. Additionally, technological advancements, such as the development of high-throughput diagnostic systems and automation in laboratories, are significantly improving diagnostic accuracy and efficiency. However, the high costs associated with allergy diagnostic tests and the limited access to advanced healthcare in emerging markets pose challenges. The market is also witnessing strategic mergers, acquisitions, and partnerships among key players, focusing on enhancing their diagnostic portfolios and expanding their geographical reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Diagnostics Market Segmental Analysiss

Global Allergy Diagnostics Market is segmented by product, allergen, test type, end user, and region. Based on Product, the market is segmented into Consumables, Instruments (Immunoassay Analyzers, ELISA Analyzers, Luminometers, Other Instruments), Services. Based on Allergens, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens. Based on Test type, the market is segmented into Vivo Tests (Skin Prick Tests, Patch Tests, Other In Vivo Tests), In Vitro Tests. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Allergy Diagnostics Market

One of the key drivers of the allergy diagnostics market is the increasing prevalence of allergic conditions, such as allergic rhinitis, asthma, food allergies, and skin allergies, worldwide. Rapid industrialization, urbanization, and rising pollution levels contribute to heightened allergen exposure, especially in urban areas. Environmental pollutants, such as particulate matter, pollen, and dust, are major triggers for allergic reactions, and their growing presence in both developed and developing nations is fueling demand for diagnostic tools. Moreover, lifestyle factors, including changes in diet, increased consumption of processed foods, and altered microbiomes, are playing a role in the surge of food allergies, particularly among children. This rising burden of allergies is creating an urgent need for early and accurate diagnosis, with governments and healthcare providers prioritizing the development and dissemination of advanced allergy testing technologies.

Restraints in the Global Allergy Diagnostics Market

Despite the market's growth potential, one of the significant restraints is the high cost of allergy diagnostic tests, which limits their widespread adoption, particularly in low- and middle-income countries. Allergy diagnostics, especially advanced techniques like molecular diagnostics and component-resolved diagnostics (CRD), often require sophisticated equipment and specialized training, leading to increased operational costs. These costs are passed on to patients, making the tests unaffordable for many, especially in regions with limited healthcare reimbursement systems. Even in developed markets, where healthcare systems are more robust, insurance coverage for allergy diagnostics can be inconsistent, leaving patients with substantial out-of-pocket expenses. As healthcare budgets tighten and cost-containment becomes a priority for many governments, the high cost of allergy diagnostics could hinder broader market penetration, particularly among the uninsured or underinsured populations.

Market Trends of the Global Allergy Diagnostics Market

One of the emerging trends in the allergy diagnostics market is the increasing use of point-of-care (POC) testing, which allows for faster and more convenient allergy testing outside traditional laboratory settings. POC tests offer significant advantages, including shorter turnaround times, ease of use, and the ability to perform tests in clinics or even at home, which is particularly valuable in remote or underserved areas with limited access to healthcare facilities. The rise of at-home testing kits for allergies, especially in the context of increasing consumer demand for personalized healthcare solutions, is driving this trend. Moreover, technological advancements are improving the accuracy and reliability of POC tests, making them comparable to conventional laboratory-based methods. This shift towards decentralized testing aligns with broader healthcare trends focusing on patient-centric care and improved accessibility. As this trend continues to evolve, it is expected to open new opportunities for market players to innovate and expand their diagnostic offerings.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Trade Analysis
• Technology Analysis
• Customer & Buying Criteria Analysis

Allergy Diagnostics Market, By Product & Service

• Market Overview
• Consumables
• Instruments
  • Immunoassay Analyzers
  • Luminometers
  • Other Instruments
• Services

Allergy Diagnostics Market, By Test Type

• Market Overview
• In Vivo Tests
  • Skin Prick Tests
  • Patch Tests
  • Other In Vivo Tests
• In Vitro Tests

Allergy Diagnostics Market, By Allergen

• Market Overview
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

Allergy Diagnostics Market, By End User

• Market Overview
• Hospital-Based Laboratories & Clinics
• Diagnostic Laboratories
• Academic Research Institutes
• Other End Users

Allergy Diagnostics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux Sa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romer Labs Division Holding Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hollisterstier Allergy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Diagnostics Group Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hycor Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astra Biotech Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Erba Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dst Diagnostische Systeme & Technologien Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Fooke Laboratorien GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments